- Trials with a EudraCT protocol (53)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (9)
53 result(s) found for: Stomatitis.
Displaying page 1 of 3.
EudraCT Number: 2006-003260-53 | Sponsor Protocol Number: 102010 | Start Date*: 2006-07-24 | |||||||||||
Sponsor Name:Danmarks Farmaceutiske Universitet | |||||||||||||
Full Title: Lokal administration af morfin: Evaluering af den smertestillende effekt på stomatitis hos børn. | |||||||||||||
Medical condition: Stomatitis som bivirkning til kemoterapi. | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-000821-74 | Sponsor Protocol Number: KKS-MS-006KMT-01/06 | Start Date*: 2006-12-08 | |||||||||||
Sponsor Name:University Hospital of Muenster | |||||||||||||
Full Title: A randomized. double-blind, placebo-controlled, phase III trial for the efficacy of Traumeel S in the prevention and treatment of chemotherapie-induced Mucositis in Patients undergoing allogeneic s... | |||||||||||||
Medical condition: Treatment of chemotherapie-induced oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-000343-11 | Sponsor Protocol Number: OC005OMBMT | Start Date*: 2013-05-10 | |||||||||||
Sponsor Name:Clinical Research Centre, Hvidovre University Hospital | |||||||||||||
Full Title: Clinical trial with lozenges as local anesthesia for allogeneic bone marrow transplant patients with oral mucositis | |||||||||||||
Medical condition: Oral pain due to oral mucositis in patients undergoing a bone marrow transplant | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002340-42 | Sponsor Protocol Number: SBG-2-03 | Start Date*: 2008-09-16 | |||||||||||
Sponsor Name:Biotec Pharmacon ASA | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel-group phase III clinical study to assess the efficacy and safety of soluble beta 1,3/1,6 glucan (SBG) on oral mucositis in head and neck can... | |||||||||||||
Medical condition: Oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004749-14 | Sponsor Protocol Number: 07_DOG13_104 | Start Date*: 2009-02-12 | ||||||||||||||||
Sponsor Name:Christie Hospital NHS Foundation Trust | ||||||||||||||||||
Full Title: Assessing the Feasibility of a Single Blind Randomised Controlled Trial to Measure the Effectiveness of D-Alpha-Tocopherol in the Management of Oral Mucositis in Patients Undergoing Conditioning fo... | ||||||||||||||||||
Medical condition: This trial will assess the D-alpha-Tocopherol in the management of Oral Mucositis. Nutritional status will be assessed using the patient generated subjective oral assessment tool to monitor cancer... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-020660-37 | Sponsor Protocol Number: CR3294-2-01 | Start Date*: 2010-09-08 | ||||||||||||||||
Sponsor Name:ROTTAPHARM S.P.A. | ||||||||||||||||||
Full Title: A Multicenter, randomized, double blind, double dummy, placebo controlled, parallel group, phase II study on the prevention of mucositis by CR3294, orally administered for 5 days in haematological ... | ||||||||||||||||||
Medical condition: assessment of the effect of CR3294 in preventing oral mucositis induced by conditioning myeloablative regimens in patients undergoing high-dose chemotherapy (HDCT) and autologous HSCT. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-005565-54 | Sponsor Protocol Number: SBG-2-04 | Start Date*: 2008-12-08 | |||||||||||
Sponsor Name:Biotec Pharmacon ASA | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel-group phase III clinical study to assess the efficacy and safety of soluble beta 1,3/1,6 glucan (SBG) on oral mucositis in head and neck can... | |||||||||||||
Medical condition: Oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006549-42 | Sponsor Protocol Number: EN3285-302 | Start Date*: 2008-06-11 | |||||||||||
Sponsor Name:Endo Pharmaceuticals Inc. | |||||||||||||
Full Title: A Phase 3, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of EN3285 for the Prevention or Delay to Onset of Severe Oral Mucositis in Subjects wi... | |||||||||||||
Medical condition: Severe Oral Mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002346-42 | Sponsor Protocol Number: P2HNC01 | Start Date*: 2014-09-12 | ||||||||||||||||
Sponsor Name:Copenhagen University Hospital, Hvidovre | ||||||||||||||||||
Full Title: Clinical trial with lozenges as local pain treatment for head and neck cancer patients with oral mucostis | ||||||||||||||||||
Medical condition: Oral pain due to oral mucositis in head and neck cancer patients which are undergoing radiation therapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004504-36 | Sponsor Protocol Number: 801-00 | Start Date*: 2005-12-20 | |||||||||||
Sponsor Name:Merck & Co., Inc. | |||||||||||||
Full Title: A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of Caspofungin in the Treatment of Invasive Candidiasis in Adults. | |||||||||||||
Medical condition: Candidiasis (invasive) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) IT (Completed) PT (Completed) DE (Completed) LV (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-001964-11 | Sponsor Protocol Number: 2019/0411/HP | Start Date*: 2021-12-17 | |||||||||||
Sponsor Name:CHU de Rouen | |||||||||||||
Full Title: Randomized double blind controlled trial comparing the safety and efficacy of apremilast versus placebo in severe forms of recurrent aphthous stomatitis | |||||||||||||
Medical condition: Patients with severe forms of Recurrent Aphthous Stomatitis (RAS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006409-18 | Sponsor Protocol Number: 9463-EC-0002 | Start Date*: 2010-02-09 | ||||||||||||||||
Sponsor Name:Astellas Pharma Europe Ltd. | ||||||||||||||||||
Full Title: An Exploratory Study to Compare the Efficacy and Safety of Micafungin as a Pre-emptive Treatment of Invasive Candidiasis versus Placebo in High Risk Surgical Subjects - A Multicentre, Randomized, D... | ||||||||||||||||||
Medical condition: Invasive Candidiasis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) ES (Completed) HU (Completed) BE (Completed) GR (Completed) DE (Completed) FR (Completed) FI (Completed) IT (Completed) GB (Completed) DK (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-015159-26 | Sponsor Protocol Number: UKW-Inf-001 | Start Date*: 2011-03-14 | ||||||||||||||||||||||||||
Sponsor Name:Universitaetsklinikum Wuerzburg | ||||||||||||||||||||||||||||
Full Title: UKW-Inf-001: Prospective trial to evaluate pharmacokinetic, safety and efficacy of intermittent application of increased doses of caspofungin for antifungal prophylaxis in high risk patients. | ||||||||||||||||||||||||||||
Medical condition: Prophylaxis of invasive fungal infection, including life-threatening aspergillosis and candidiasis, is investigated in the study. Patient with acute myeloid leukemia or acute lymphatic leukemia wil... | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001716-31 | Sponsor Protocol Number: 20040124 | Start Date*: 2015-09-17 | |||||||||||
Sponsor Name:Swedish Orphan Biovitrum AB (publ.) | |||||||||||||
Full Title: A Phase 1/2 Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduct... | |||||||||||||
Medical condition: Oral Mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-000213-35 | Sponsor Protocol Number: 20020402 | Start Date*: 2005-08-05 | |||||||||||
Sponsor Name:Swedish Orphan Biovitrum AB (publ.) | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduct... | |||||||||||||
Medical condition: Oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) HU (Completed) AT (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-003709-15 | Sponsor Protocol Number: 20050219 | Start Date*: 2006-11-08 | ||||||||||||||||
Sponsor Name:Swedish Orphan Biovitrum AB (publ) | ||||||||||||||||||
Full Title: A Double-Blind, Randomized, Placebo-controlled Study of Two Different Schedules of Palifermin (Pre- and Post Chemotherapy and Pre-Chemotherapy only) for Reduction in Severity of Oral Mucositis in S... | ||||||||||||||||||
Medical condition: Oral Mucositis Induced by High Dose Chemotherapy Cataract development associated with palifermin administration | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) HU (Completed) CZ (Completed) IE (Completed) AT (Completed) BE (Completed) FI (Completed) SE (Completed) DE (Completed) DK (Completed) IT (Completed) NL (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-005007-14 | Sponsor Protocol Number: 20040122 | Start Date*: 2005-05-20 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of Palifermin (Recombinant Human Keratinocyte Growth Factor) for Reduction of Oral Mucositis in Subjects Wit... | |||||||||||||
Medical condition: Oral Mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) CZ (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-000999-11 | Sponsor Protocol Number: MNPR-301-001 | Start Date*: 2021-09-23 | |||||||||||
Sponsor Name:Monopar Therapeutics Inc. | |||||||||||||
Full Title: A Phase 2b/3, multicenter, randomized, double-blind, placebocontrolled study comparing the efficacy and safety of clonidine mucoadhesive buccal tablet to placebo to prevent chemoradiotherapy-induce... | |||||||||||||
Medical condition: Chemoradiotherapy (CRT)-induced severe oral mucositis (SOM) in patients with oropharyngeal cancer (OPC) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001193-15 | Sponsor Protocol Number: FASTERCC-001 | Start Date*: 2016-07-06 | |||||||||||||||||||||||||||||||
Sponsor Name:Department of Oncology, Aarhus University Hospital | |||||||||||||||||||||||||||||||||
Full Title: Folic acid supplement versus placebo for treating mucositis adverse events in metastatic renal cell carcinoma patients receiving targeted therapy (FASTERCC). A randomized, double-blind, phase II ... | |||||||||||||||||||||||||||||||||
Medical condition: Mucositis (nasal, oral, pharyngeal, anal, or genital) is often experienced in relation to TKI and mTOR inhibitor treatment of metastatic renal cell carcinoma patients. The present trial will assess... | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002016-28 | Sponsor Protocol Number: 20040118 | Start Date*: 2005-01-04 | |||||||||||
Sponsor Name:Amgen | |||||||||||||
Full Title: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Weekly Doses of Palifermin (Recombinant Human Keratinocyte Growth Factor, rHuKGF) for the Reduct... | |||||||||||||
Medical condition: Oral mucositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) GB (Completed) AT (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
